Multiple fractions daily for head and neck cancer: Spinal cord effects and other late results

Reports of late spinal cord damage after multiple fractions daily radiotherapy regimens for head and neck cancer are infrequent, but increasing. We have reviewed our experience of head and neck cancers treated thrice daily to examine this problem. Between 1982 and 1990, 65 patients with advanced hea...

Full description

Saved in:
Bibliographic Details
Published inClinical oncology (Royal College of Radiologists (Great Britain)) Vol. 5; no. 3; pp. 139 - 142
Main Authors Crellin, R.P., Macmillan, C.H., Berridge, J.K., Morgan, D.A.L.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 1993
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Reports of late spinal cord damage after multiple fractions daily radiotherapy regimens for head and neck cancer are infrequent, but increasing. We have reviewed our experience of head and neck cancers treated thrice daily to examine this problem. Between 1982 and 1990, 65 patients with advanced head and neck cancer were treated by primary radiotherapy using three small fractions delivered on 5 days per week, with an inter-fraction interval of 3–4 hours during normal working hours. In 25 patients, the cervical spinal cord received >39 Gy. In 13 patients, 39.6 Gy was given in 1.1 Gy fractions, and five received 41.8 Gy in 1.1 Gy fractions, two received 45.1 Gy in 1.1 Gy fractions and five received 45 Gy in 1.5 Gy fractions. Eleven of these patients have survived over 2 years, and can be assessed for late spinal cord damage. Ten of these received 1.1 Gy fractions with no cord damage. The only 2-year survivor whose cord received 45 Gy in 1.5 Gy fractions has developed mild, non-progressive long tract signs. Other late side effects were equivalent to those after conventionally fractionated radiotherapy. Tumour control was good, especially for the larynx. We feel that, for radiotherapy given with three small fractions daily and an inter-fraction interval of 3–4 hours, the spinal dose should not exceed 40 Gy.
AbstractList Reports of late spinal cord damage after multiple fractions daily radiotherapy regimens for head and neck cancer are infrequent, but increasing. We have reviewed our experience of head and neck cancers treated thrice daily to examine this problem. Between 1982 and 1990, 65 patients with advanced head and neck cancer were treated by primary radiotherapy using three small fractions delivered on 5 days per week, with an inter-fraction interval of 3-4 hours during normal working hours. In 25 patients, the cervical spinal cord received > 39 Gy. In 13 patients, 39.6 Gy was given in 1.1 Gy fractions, and five received 41.8 Gy in 1.1 Gy fractions, two received 45.1 Gy in 1.1 Gy fractions and five received 45 Gy in 1.5 Gy fractions. Eleven of these patients have survived over 2 years, and can be assessed for late spinal cord damage. Ten of these received 1.1 Gy fractions with no cord damage. The only 2-year survivor whose cord received 45 Gy in 1.5 Gy fractions has developed mild, non-progressive long tract signs. Other late side effects were equivalent to those after conventionally fractionated radiotherapy. Tumour control was good, especially for the larynx. We feel that, for radiotherapy given with three small fractions daily and an inter-fraction interval of 3-4 hours, the spinal dose should not exceed 40 Gy.
Reports of late spinal cord damage after multiple fractions daily radiotherapy regimens for head and neck cancer are infrequent, but increasing. We have reviewed our experience of head and neck cancers treated thrice daily to examine this problem. Between 1982 and 1990, 65 patients with advanced head and neck cancer were treated by primary radiotherapy using three small fractions delivered on 5 days per week, with an inter-fraction interval of 3–4 hours during normal working hours. In 25 patients, the cervical spinal cord received >39 Gy. In 13 patients, 39.6 Gy was given in 1.1 Gy fractions, and five received 41.8 Gy in 1.1 Gy fractions, two received 45.1 Gy in 1.1 Gy fractions and five received 45 Gy in 1.5 Gy fractions. Eleven of these patients have survived over 2 years, and can be assessed for late spinal cord damage. Ten of these received 1.1 Gy fractions with no cord damage. The only 2-year survivor whose cord received 45 Gy in 1.5 Gy fractions has developed mild, non-progressive long tract signs. Other late side effects were equivalent to those after conventionally fractionated radiotherapy. Tumour control was good, especially for the larynx. We feel that, for radiotherapy given with three small fractions daily and an inter-fraction interval of 3–4 hours, the spinal dose should not exceed 40 Gy.
Author Macmillan, C.H.
Berridge, J.K.
Morgan, D.A.L.
Crellin, R.P.
Author_xml – sequence: 1
  givenname: R.P.
  surname: Crellin
  fullname: Crellin, R.P.
  organization: Department of Clinical Oncology, Nottingham General Hospital, Park Row, Nottingham NG1 6HA UK
– sequence: 2
  givenname: C.H.
  surname: Macmillan
  fullname: Macmillan, C.H.
  organization: Department of Clinical Oncology, Northampton General Hospital, Northampton NN1 5BD, UK
– sequence: 3
  givenname: J.K.
  surname: Berridge
  fullname: Berridge, J.K.
  organization: Department of Clinical Oncology, Nottingham General Hospital, Park Row, Nottingham NG1 6HA UK
– sequence: 4
  givenname: D.A.L.
  surname: Morgan
  fullname: Morgan, D.A.L.
  organization: Department of Clinical Oncology, Nottingham General Hospital, Park Row, Nottingham NG1 6HA UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/8347535$$D View this record in MEDLINE/PubMed
BookMark eNqFkDtPwzAQxy0EKm3hI1TyCEPATmrHZkGo4iUVMRRGZDnni2pIk8hOkfrtSR_qynTD_3F3vxE5rZsaCZlwdsMZl7cLpjOZSCHEFRPXimVMJ_kJGfJpliWpVvyUDI-WczKK8ZsxliqlB2SgsmkuMjEkX2_rqvNthbQMFjrf1JE666sNLZtAl2gdtbWjNcIPBVsDhju6aH1tKwpNcBTLEqGLO1PTLTHQynZIA8a-N16Qs9JWES8Pc0w-nx4_Zi_J_P35dfYwTyDNRZe4FABTB8BTjoW0yqlc5TbHlINUoii0Zc4WhQQukTunhWISNWhbSlHILBsTse-F0MQYsDRt8CsbNoYzs6VldrTMFoVhwuxombzPTfa5dl2s0B1TBzy9fr_XsT_-12MwETz2FJwP_dvGNf6fDX_JvX0Q
CitedBy_id crossref_primary_10_3109_02841869609101661
crossref_primary_10_1007_BF01053419
crossref_primary_10_1016_0360_3016_92_90943_C
ContentType Journal Article
Copyright 1993 The Royal College of Radiologists
Copyright_xml – notice: 1993 The Royal College of Radiologists
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.1016/S0936-6555(05)80309-7
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1433-2981
EndPage 142
ExternalDocumentID 10_1016_S0936_6555_05_80309_7
8347535
S0936655505803097
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29B
4.4
457
4G.
53G
5GY
5RE
5VS
6PF
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAWTL
AAXUO
ABBQC
ABJNI
ABLJU
ABLVK
ABMAC
ABMZM
ABOCM
ABXDB
ABYKQ
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
ADFGL
ADMUD
AEBSH
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DM4
DU5
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HED
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LAS
LCYCR
M27
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SDF
SDG
SDH
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
UDS
UHS
WOW
WUQ
Z5R
~G-
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAXKI
AAYXX
CITATION
ID FETCH-LOGICAL-c275t-d2cce2dcc121eb6a8d8787a7e21c685bb9a0dabb6c16e1dd95806e9c9af65b633
ISSN 0936-6555
IngestDate Thu Sep 12 19:32:53 EDT 2024
Thu May 23 23:52:24 EDT 2024
Fri Feb 23 02:30:39 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Spinal cord
Hyperfractionation
Radiation damage
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c275t-d2cce2dcc121eb6a8d8787a7e21c685bb9a0dabb6c16e1dd95806e9c9af65b633
PMID 8347535
PageCount 4
ParticipantIDs crossref_primary_10_1016_S0936_6555_05_80309_7
pubmed_primary_8347535
elsevier_sciencedirect_doi_10_1016_S0936_6555_05_80309_7
PublicationCentury 1900
PublicationDate 1993
1993-00-00
PublicationDateYYYYMMDD 1993-01-01
PublicationDate_xml – year: 1993
  text: 1993
PublicationDecade 1990
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Clinical oncology (Royal College of Radiologists (Great Britain))
PublicationTitleAlternate Clin Oncol (R Coll Radiol)
PublicationYear 1993
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Elkind, Sutton-Gilbert, Moses (bib9) 1965; 25
Hopewell, Morris, Dixon-Brown (bib12) 1987; 60
van der Schueren, Landuyt, Ang (bib15) 1988; 14
Bradley, Morgan (bib1) 1991; 104
Dische (bib14) 1991; 20
Sule-Suso, Brunt, Lindup (bib17) 1991; 3
Lindup (bib16) 1992; 4
van der Kogel (bib3) 1989; 16
Dische, Saunders (bib7) 1990; 19
Morgan, Bradley, Maclennan (bib2) 1987; 26
Lavey, Johnston, McBride (bib13) 1992; 24
Ang, Jiang, Guttenburger (bib10) 1992; 25
Wang (bib8) 1988; 14
(bib6) 1986; 12
Brunt, Sule-Suso, Scoble (bib18) 1992; 4
Dische, Saunders (bib5) 1989; 16
Wong, van Dyk, Simpson (bib4) 1991; 20
van de Bogaert, van der Schueren, Horiot (bib11) 1982; 8
References_xml – volume: 8
  start-page: 1649
  year: 1982
  end-page: 1655
  ident: bib11
  article-title: The feasibility of high dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Horiot
– volume: 60
  start-page: 1099
  year: 1987
  end-page: 1108
  ident: bib12
  article-title: The influence of field size on the late tolerance of the rat spinal cord to single doses of X-rays
  publication-title: Br J Radiol
  contributor:
    fullname: Dixon-Brown
– volume: 3
  start-page: 209
  year: 1991
  end-page: 213
  ident: bib17
  article-title: Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus
  publication-title: Clin Oncol
  contributor:
    fullname: Lindup
– volume: 4
  start-page: 340
  year: 1992
  ident: bib18
  article-title: Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus [letter]
  publication-title: Clin Oncol
  contributor:
    fullname: Scoble
– volume: 24
  start-page: 681
  year: 1992
  end-page: 686
  ident: bib13
  article-title: The effect of hyper-fractionation on spinal cord response to radiation
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: McBride
– volume: 26
  start-page: 437
  year: 1987
  end-page: 440
  ident: bib2
  article-title: Early results of radiotherapy for advanced laryngeal cancer using three small fractions per day
  publication-title: Acta Oncol
  contributor:
    fullname: Maclennan
– volume: 25
  start-page: 287
  year: 1992
  end-page: 294
  ident: bib10
  article-title: Impact of spinal cord repair kinetics on the practice of altered fractionation schedules
  publication-title: Radiother Oncol
  contributor:
    fullname: Guttenburger
– volume: 104
  start-page: 838
  year: 1991
  end-page: 841
  ident: bib1
  article-title: Radiotherapy of advanced laryngeal cancer using three small fractions daily
  publication-title: Otolaryngol Head Neck Surg
  contributor:
    fullname: Morgan
– volume: 19
  start-page: 1317
  year: 1990
  end-page: 1320
  ident: bib7
  article-title: The rationale for continuous hyperfractionated accelerated radiotherapy (CHART)
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Saunders
– volume: 14
  start-page: 209
  year: 1988
  end-page: 210
  ident: bib8
  article-title: The enigma of accelerated hyperfractionated radiation therapy for head and neck cancer
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Wang
– volume: 12
  start-page: 587
  year: 1986
  end-page: 591
  ident: bib6
  article-title: Early results of the EORTC randomised clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 25
  start-page: 359
  year: 1965
  end-page: 376
  ident: bib9
  article-title: Radiation response of mammalian cells
  publication-title: Radiat Res
  contributor:
    fullname: Moses
– volume: 16
  start-page: 75
  year: 1989
  end-page: 77
  ident: bib3
  article-title: Continuous, hyperfractionated, accelerated radiotherapy (CHART) [editorial comment]
  publication-title: Radiother Oncol
  contributor:
    fullname: van der Kogel
– volume: 16
  start-page: 67
  year: 1989
  end-page: 74
  ident: bib5
  article-title: Continuous hyperfractionated accelerated radiotherapy (CHART): An interim report upon late morbidity
  publication-title: Radiother Oncol
  contributor:
    fullname: Saunders
– volume: 20
  start-page: 3
  year: 1991
  end-page: 9
  ident: bib4
  article-title: Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma
  publication-title: Radiother Oncol
  contributor:
    fullname: Simpson
– volume: 14
  start-page: 297
  year: 1988
  end-page: 300
  ident: bib15
  article-title: From 2 Gy to 1 Gy per fraction: Sparing effect in rat spinal cord
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Ang
– volume: 20
  start-page: 1
  year: 1991
  end-page: 2
  ident: bib14
  article-title: Accelerated treatment and radiation myelitis [editorial]
  publication-title: Radiother Oncol
  contributor:
    fullname: Dische
– volume: 4
  start-page: 280
  year: 1992
  end-page: 283
  ident: bib16
  article-title: Multiple fractions in the treatment of head and neck cancer
  publication-title: Clin Oncol
  contributor:
    fullname: Lindup
SSID ssj0002889
Score 1.4297734
Snippet Reports of late spinal cord damage after multiple fractions daily radiotherapy regimens for head and neck cancer are infrequent, but increasing. We have...
SourceID crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 139
SubjectTerms Carcinoma, Squamous Cell - radiotherapy
Head and Neck Neoplasms - radiotherapy
Humans
Hyperfractionation
Laryngeal Neoplasms - radiotherapy
Pharyngeal Neoplasms - radiotherapy
Radiation damage
Radiotherapy - adverse effects
Radiotherapy Dosage
Spinal cord
Spinal Cord - radiation effects
Title Multiple fractions daily for head and neck cancer: Spinal cord effects and other late results
URI https://dx.doi.org/10.1016/S0936-6555(05)80309-7
https://www.ncbi.nlm.nih.gov/pubmed/8347535
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JbxMxFLZCKlAviK2ibPKBAyiaMPaMPTa3EoGqVuFQWtELGnmbCzCNkvTC7-GH8rzMIhFU4GIls9jJe9_Yz9-8BaGXjWKNIYpklmqdlU3D4ZFiZaaoY8w4S5z11MDyIz--KE8u2eVk8nPktXS91XPzY2dcyf9oFY6BXn2U7D9otu8UDsBn0C-0oGFo_0rHy84bsFnH-ITNzCrPV3jfQZhlQxrWWevMV-_cZVwoCblZhUJYftfZe3P4y0Io1uwb2J4z2IJDz5ux4broIiivWhPTNu3iHs6UDeEvgJ3NLgJixDss1j4VaGQAhiCzrg5SdAUYIife-QSSqQz8yUDNLkNRqjBvJlLWpoi-YsxBFjzjLObpnbs4A5ehuFys49JN0WyExGI03ZKYCOm3ZSAyEp_6_uEP59BIEV4oVeN7QPCr7wEfoihh78aGhbF3V0xnbqE9WsF-cor2jk7PPp_2Kz4VIuZ0TMMNkWJvht_wKmev0_j76Hbq8gZraGTqnN9Dd9MeBR9FwN1HE9c-QHeWyQvjIfrS4Q73uMMBdxhwhz3uMAAKe9zhiLu3OKIOe9ThhLpwUUAd9qjDCXWP0MWH9-eL4yyV6cgMrdgWnnJjHLXGEEqc5kpYAauAqhwlhgumtVS5VVpzQ7gj1komcu6kkarhTPOiOEDT9qp1jxHObWO5FCWxsikraSUxynHu0zVYCl8P0bwTV72K2VjqwU0RJF17Sdc5q4Ok6-oQiU6odTIpo6lYA1RuuvUgKqEfKensyZ9OPEX70R3WE3TP0HS7vnbPwWTd6hcJMb8AR6OQWA
link.rule.ids 315,786,790,4043,27956,27957,27958
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multiple+fractions+daily+for+head+and+neck+cancer%3A+spinal+cord+effects+and+other+late+results&rft.jtitle=Clinical+oncology+%28Royal+College+of+Radiologists+%28Great+Britain%29%29&rft.au=Crellin%2C+R+P&rft.au=Macmillan%2C+C+H&rft.au=Berridge%2C+J+K&rft.au=Morgan%2C+D+A&rft.date=1993&rft.issn=0936-6555&rft.eissn=1433-2981&rft.volume=5&rft.issue=3&rft.spage=139&rft_id=info:doi/10.1016%2FS0936-6555%2805%2980309-7&rft_id=info%3Apmid%2F8347535&rft.externalDocID=8347535
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0936-6555&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0936-6555&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0936-6555&client=summon